| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Pulmonary Disease Section, Veterans Administration Medical Center, Portland; and the College of Health and Physical Education and Department of Statistics, Oregon State University, Corvallis
The 1969 Oregon spirometric predictive equations were evaluated by retesting 199 of the 988 original sample population after 15 years. The 1969 data were used to test for sample bias between the retested and not-retested groups. There was no significant difference in mean values for age, height, or test results except for a five-year age difference in men. Regression analysis of residuals and the differences between calculated and predicted values of annual decrements of FVC, FEV1, and FEF25-75% on age revealed no statistically significant age trend. Although residual means were statistically significant for FVC and FEV1 for men and FVC and FEF25-75% for women, the differences between calculated and predicted annual decrements were significant only for women in FEF25-75%. Although group performance was accurately predicted for most tests, test SDs and SEMs demonstrated considerable individual variation. Lower limits of normality are suggested to assist in evaluating previously-tested patients.
Submitted on March 20, 2007
This article has been cited by other articles:
|
|
 |
|
  C. de Bisschop, M. L. Marty, J. F. Tessier, P. Barberger-Gateau, J. F. Dartigues, and H. Guenard Expiratory flow limitation and obstruction in the elderly Eur. Respir. J., October 1, 2005; 26(4): 594 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Niewoehner, K. Rice, C. Cote, D. Paulson, J. A. D. Cooper Jr., L. Korducki, C. Cassino, and S. Kesten Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator: A Randomized Trial Ann Intern Med, September 6, 2005; 143(5): 317 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Parker, N. Voduc, S. D. Aaron, K. A. Webb, and D. E. O'Donnell Physiological changes during symptom recovery from moderate exacerbations of COPD Eur. Respir. J., September 1, 2005; 26(3): 420 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Casaburi, D. Kukafka, C. B. Cooper, T. J. Witek Jr, and S. Kesten Improvement in Exercise Tolerance With the Combination of Tiotropium and Pulmonary Rehabilitation in Patients With COPD Chest, March 1, 2005; 127(3): 809 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Garcia-Rio, J.M. Pino, A. Dorgham, A. Alonso, and J. Villamor Spirometric reference equations for European females and males aged 65-85 yrs Eur. Respir. J., September 1, 2004; 24(3): 397 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.E. O'Donnell, N. Voduc, M. Fitzpatrick, and K.A. Webb Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease Eur. Respir. J., July 1, 2004; 24(1): 86 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Tashkin and S. Kesten Long-term Treatment Benefits With Tiotropium in COPD Patients With and Without Short-term Bronchodilator Responses Chest, May 1, 2003; 123(5): 1441 - 1449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Casaburi, D.A. Mahler, P.W. Jones, A. Wanner, G. San Pedro, R.L. ZuWallack, S.S. Menjoge, C.W. Serby, and T. Witek Jr A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease Eur. Respir. J., February 1, 2002; 19(2): 217 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.E. O'Donnell, L. Forkert, and K.A. Webb Evaluation of bronchodilator responses in patients with "irreversible" emphysema Eur. Respir. J., December 1, 2001; 18(6): 914 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Taylor, A. Kotch, K. Rice, M. Ghafouri, C. L. Kurland, N. M. Fagan, and T. J. Witek Jr Ipratropium Bromide Hydrofluoroalkane Inhalation Aerosol Is Safe and Effective in Patients With COPD Chest, October 1, 2001; 120(4): 1253 - 1261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. O'DONNELL, S. M. REVILL, and K. A. WEBB Dynamic Hyperinflation and Exercise Intolerance in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 770 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Casaburi, D. D. Briggs Jr., J. F. Donohue, C. W. Serby, S. S. Menjoge, and T. J. Witek Jr. The Spirometric Efficacy of Once-Daily Dosing With Tiotropium in Stable COPD : A 13-Week Multicenter Trial Chest, November 1, 2000; 118(5): 1294 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. LITTNER, J. S. ILOWITE, D. P. TASHKIN, M. FRIEDMAN, C. W. SERBY, S. S. MENJOGE, and T. J. WITEK Jr. Long-Acting Bronchodilation with Once-Daily Dosing of Tiotropium (Spiriva) in Stable Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1136 - 1142. [Abstract] [Full Text]
|
|
|
|
|
|
A. E. V. Andel, C. Reisner, S. S. Menjoge, and T. J. Witek Analysis of Inhaled Corticosteroid and Oral Theophylline Use Among Patients With Stable COPD from 1987 to 1995 Chest, March 1, 1999; 115(3): 703 - 707. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
